Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Memory Disorders × Pioglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms, Castration-Resistant 1 Pharmacokinetics of MDV3100 1 Neoplasm Metastasis 1 Meningioma 1 Memory Disorders 1 Glioblastoma 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01151670 2018-08-01

Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

Wake Forest University Health Sciences

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Memory Disorders, Meningioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡